(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with homovanillic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickinson, SD; Gerhardt, GA; Giardina, K; Grandy, DK; Kelly, MA; Larson, GA; Low, MJ; Rubinstein, M; Sabeti, J; Zahniser, NR | 1 |
| Brashear, A; Farlow, MR; Hutchins, GD; Mulholland, GK; Siemers, ER; Zheng, QH | 1 |
| Cho, AK; Kuczenski, R; Melega, WP; O'Neil, ML; Segal, DS | 1 |
| Cho, AK; Kuczenski, R; Lacan, G; Melega, WP; O'Neil, ML; Segal, DS | 1 |
| Di Monte, DA; Guillot, TS; Hatcher, JM; Jones, DP; McCormack, AL; Miller, GW; Pennell, KD; Richardson, JR | 1 |
5 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and homovanillic acid
| Article | Year |
|---|---|
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoreceptors; Brain Chemistry; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Extracellular Space; Female; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Microdialysis; Nerve Tissue Proteins; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Tritium | 1999 |
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
Topics: Adult; Aged; Brain Mapping; Carbon Radioisotopes; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Uptake Inhibitors; Dystonia; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed | 1999 |
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Body Temperature; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tetrabenazine; Time Factors; Tritium | 2003 |
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamine-Related Disorders; Animals; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 2006 |
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dieldrin; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Organ Culture Techniques; Oxidative Stress; Protein Carbonylation; Substantia Nigra | 2007 |